Computational design and biological testing of highly cytotoxic colchicine ring a modifications

John Torin Huzil, Philip Winter, Lorelei Johnson, Alexander L. Weis, Tamas Bakos, Asok Banerjee, Richard F. Luduena, Sambasivarao Damaraju, Jack A. Tuszynski

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Microtubules are the primary target for many anti-cancer drugs, the majority of which bind specifically to β-tubulin. The existence of several β-tubulin isotypes, coupled with their varied expression in normal and cancerous cells provides a platform upon which to construct selective chemotherapeutic agents. We have examined five prevalent human β-tubulin isotypes and identified the colchicine-binding site as the most promising for drug design based on specificity. Using this binding site as a template, we have designed several colchicine derivatives and computationally probed them for affinity to the β-tubulin isotypes. These compounds were synthesized and subjected to cytotoxicity assays to determine their effectiveness against several cancerous cell lines. We observed a correlation between computational-binding predictions and experimentally determined IC50 values, demonstrating the utility of computational screening in the design of more effective colchicine derivatives. The most promising derivative exhibited an IC50 approximately threefold lower than values previously reported for either colchicine or paclitaxel, demonstrating the utility of computational design and assessment of binding to tubulin.

Original languageEnglish (US)
Pages (from-to)541-550
Number of pages10
JournalChemical Biology and Drug Design
Volume75
Issue number6
DOIs
StatePublished - Jun 2010

Fingerprint

Colchicine
Tubulin
Testing
Derivatives
Inhibitory Concentration 50
Binding Sites
Drug Design
Cytotoxicity
Paclitaxel
Microtubules
Pharmaceutical Preparations
Assays
Screening
Cells
Cell Line
Neoplasms

Keywords

  • Colchicine
  • Cytotoxicity
  • Docking
  • Molecular modeling
  • Rational drug design

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

Torin Huzil, J., Winter, P., Johnson, L., Weis, A. L., Bakos, T., Banerjee, A., ... Tuszynski, J. A. (2010). Computational design and biological testing of highly cytotoxic colchicine ring a modifications. Chemical Biology and Drug Design, 75(6), 541-550. https://doi.org/10.1111/j.1747-0285.2010.00970.x

Computational design and biological testing of highly cytotoxic colchicine ring a modifications. / Torin Huzil, John; Winter, Philip; Johnson, Lorelei; Weis, Alexander L.; Bakos, Tamas; Banerjee, Asok; Luduena, Richard F.; Damaraju, Sambasivarao; Tuszynski, Jack A.

In: Chemical Biology and Drug Design, Vol. 75, No. 6, 06.2010, p. 541-550.

Research output: Contribution to journalArticle

Torin Huzil, J, Winter, P, Johnson, L, Weis, AL, Bakos, T, Banerjee, A, Luduena, RF, Damaraju, S & Tuszynski, JA 2010, 'Computational design and biological testing of highly cytotoxic colchicine ring a modifications', Chemical Biology and Drug Design, vol. 75, no. 6, pp. 541-550. https://doi.org/10.1111/j.1747-0285.2010.00970.x
Torin Huzil, John ; Winter, Philip ; Johnson, Lorelei ; Weis, Alexander L. ; Bakos, Tamas ; Banerjee, Asok ; Luduena, Richard F. ; Damaraju, Sambasivarao ; Tuszynski, Jack A. / Computational design and biological testing of highly cytotoxic colchicine ring a modifications. In: Chemical Biology and Drug Design. 2010 ; Vol. 75, No. 6. pp. 541-550.
@article{08af1860195041dcb52f365ef3f05b6d,
title = "Computational design and biological testing of highly cytotoxic colchicine ring a modifications",
abstract = "Microtubules are the primary target for many anti-cancer drugs, the majority of which bind specifically to β-tubulin. The existence of several β-tubulin isotypes, coupled with their varied expression in normal and cancerous cells provides a platform upon which to construct selective chemotherapeutic agents. We have examined five prevalent human β-tubulin isotypes and identified the colchicine-binding site as the most promising for drug design based on specificity. Using this binding site as a template, we have designed several colchicine derivatives and computationally probed them for affinity to the β-tubulin isotypes. These compounds were synthesized and subjected to cytotoxicity assays to determine their effectiveness against several cancerous cell lines. We observed a correlation between computational-binding predictions and experimentally determined IC50 values, demonstrating the utility of computational screening in the design of more effective colchicine derivatives. The most promising derivative exhibited an IC50 approximately threefold lower than values previously reported for either colchicine or paclitaxel, demonstrating the utility of computational design and assessment of binding to tubulin.",
keywords = "Colchicine, Cytotoxicity, Docking, Molecular modeling, Rational drug design",
author = "{Torin Huzil}, John and Philip Winter and Lorelei Johnson and Weis, {Alexander L.} and Tamas Bakos and Asok Banerjee and Luduena, {Richard F.} and Sambasivarao Damaraju and Tuszynski, {Jack A.}",
year = "2010",
month = "6",
doi = "10.1111/j.1747-0285.2010.00970.x",
language = "English (US)",
volume = "75",
pages = "541--550",
journal = "Chemical Biology and Drug Design",
issn = "1747-0277",
publisher = "Blackwell",
number = "6",

}

TY - JOUR

T1 - Computational design and biological testing of highly cytotoxic colchicine ring a modifications

AU - Torin Huzil, John

AU - Winter, Philip

AU - Johnson, Lorelei

AU - Weis, Alexander L.

AU - Bakos, Tamas

AU - Banerjee, Asok

AU - Luduena, Richard F.

AU - Damaraju, Sambasivarao

AU - Tuszynski, Jack A.

PY - 2010/6

Y1 - 2010/6

N2 - Microtubules are the primary target for many anti-cancer drugs, the majority of which bind specifically to β-tubulin. The existence of several β-tubulin isotypes, coupled with their varied expression in normal and cancerous cells provides a platform upon which to construct selective chemotherapeutic agents. We have examined five prevalent human β-tubulin isotypes and identified the colchicine-binding site as the most promising for drug design based on specificity. Using this binding site as a template, we have designed several colchicine derivatives and computationally probed them for affinity to the β-tubulin isotypes. These compounds were synthesized and subjected to cytotoxicity assays to determine their effectiveness against several cancerous cell lines. We observed a correlation between computational-binding predictions and experimentally determined IC50 values, demonstrating the utility of computational screening in the design of more effective colchicine derivatives. The most promising derivative exhibited an IC50 approximately threefold lower than values previously reported for either colchicine or paclitaxel, demonstrating the utility of computational design and assessment of binding to tubulin.

AB - Microtubules are the primary target for many anti-cancer drugs, the majority of which bind specifically to β-tubulin. The existence of several β-tubulin isotypes, coupled with their varied expression in normal and cancerous cells provides a platform upon which to construct selective chemotherapeutic agents. We have examined five prevalent human β-tubulin isotypes and identified the colchicine-binding site as the most promising for drug design based on specificity. Using this binding site as a template, we have designed several colchicine derivatives and computationally probed them for affinity to the β-tubulin isotypes. These compounds were synthesized and subjected to cytotoxicity assays to determine their effectiveness against several cancerous cell lines. We observed a correlation between computational-binding predictions and experimentally determined IC50 values, demonstrating the utility of computational screening in the design of more effective colchicine derivatives. The most promising derivative exhibited an IC50 approximately threefold lower than values previously reported for either colchicine or paclitaxel, demonstrating the utility of computational design and assessment of binding to tubulin.

KW - Colchicine

KW - Cytotoxicity

KW - Docking

KW - Molecular modeling

KW - Rational drug design

UR - http://www.scopus.com/inward/record.url?scp=77951973915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951973915&partnerID=8YFLogxK

U2 - 10.1111/j.1747-0285.2010.00970.x

DO - 10.1111/j.1747-0285.2010.00970.x

M3 - Article

C2 - 20408852

AN - SCOPUS:77951973915

VL - 75

SP - 541

EP - 550

JO - Chemical Biology and Drug Design

JF - Chemical Biology and Drug Design

SN - 1747-0277

IS - 6

ER -